CD14 and cerebral cavernous malformation: Another recent report linked changes in circulating molecules such as ROBO4, CD14, thrombomodulin, endoglin, TSP2, and IL16 (TM) to imaging changes reflecting new symptomatic hemorrhages during the prospective follow‐up of CCM patients (Hage et al. 2025).